Cargando…

Virological and histological evaluation of intestinal samples in COVID-19 patients

BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen responsible for pandemic coronavirus disease 2019 (COVID-19). It is a highly contagious virus which primarily affects the respiratory tract, nevertheless, the lungs are not the only target organs of the virus. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuicchi, Dajana, Gabrielli, Liliana, Tardio, Maria Lucia, Rossini, Giada, D’Errico, Antonietta, Viale, Pierluigi, Lazzarotto, Tiziana, Poggioli, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730443/
https://www.ncbi.nlm.nih.gov/pubmed/36504555
http://dx.doi.org/10.3748/wjg.v28.i44.6282
_version_ 1784845672126611456
author Cuicchi, Dajana
Gabrielli, Liliana
Tardio, Maria Lucia
Rossini, Giada
D’Errico, Antonietta
Viale, Pierluigi
Lazzarotto, Tiziana
Poggioli, Gilberto
author_facet Cuicchi, Dajana
Gabrielli, Liliana
Tardio, Maria Lucia
Rossini, Giada
D’Errico, Antonietta
Viale, Pierluigi
Lazzarotto, Tiziana
Poggioli, Gilberto
author_sort Cuicchi, Dajana
collection PubMed
description BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen responsible for pandemic coronavirus disease 2019 (COVID-19). It is a highly contagious virus which primarily affects the respiratory tract, nevertheless, the lungs are not the only target organs of the virus. The intestinal tract could represent an additional tropism site for SARS-CoV-2. Several observations have collectively suggested that enteric infections can occur in COVID-19 patients. However, the detection of viral RNA in gastrointestinal (GI) tissue samples has not been adequately investigated and results are conflicting. AIM: To detect the presence of SARS-CoV-2 RNA in intestinal mucosa samples and to evaluate histological features. METHODS: The COVID-19 patients hospitalized at an Italian tertiary hospital from April 2020 to March 2021 were evaluated for enrollment in an observational, monocentric trial. The study population was composed of two groups of adult patients. In the first group (biopsy group, 30 patients), patients were eligible for inclusion if they had mild to moderate disease and if they agreed to have a rectal biopsy; in the second group (surgical specimen group, 6 patients), patients were eligible for inclusion if they underwent intestinal resection during index hospitalization. Fifty-nine intestinal mucosal samples were analyzed. RESULTS: Viral RNA was not detectable in any of the rectal biopsies performed (0/53). Histological examination showed no enterocyte damage, but slight edema of the lamina propria with mild inflammatory lymphoplasmacytic infiltration. There was no difference in inflammatory infiltrates in patients with and without GI symptoms. SARS-CoV-2 RNA was detected in fecal samples in 6 cases out of 14 cases examined (42.9%). In the surgical specimen group, all patients underwent emergency intestinal resection. Viral RNA was detected in 2 surgical specimens of the 6 examined, both of which were from patients with active neoplastic disease. Histological examination also pointed out abundant macrophages, granulocytes and plasma cells infiltrating the muscular layer and adipose tissue, and focal vasculitis. CONCLUSION: Mild-moderate COVID-19 may not be associated with rectal infection by the virus. More comprehensive autopsies or surgical specimens are needed to provide histological evidence of intestinal infection.
format Online
Article
Text
id pubmed-9730443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-97304432022-12-09 Virological and histological evaluation of intestinal samples in COVID-19 patients Cuicchi, Dajana Gabrielli, Liliana Tardio, Maria Lucia Rossini, Giada D’Errico, Antonietta Viale, Pierluigi Lazzarotto, Tiziana Poggioli, Gilberto World J Gastroenterol Observational Study BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen responsible for pandemic coronavirus disease 2019 (COVID-19). It is a highly contagious virus which primarily affects the respiratory tract, nevertheless, the lungs are not the only target organs of the virus. The intestinal tract could represent an additional tropism site for SARS-CoV-2. Several observations have collectively suggested that enteric infections can occur in COVID-19 patients. However, the detection of viral RNA in gastrointestinal (GI) tissue samples has not been adequately investigated and results are conflicting. AIM: To detect the presence of SARS-CoV-2 RNA in intestinal mucosa samples and to evaluate histological features. METHODS: The COVID-19 patients hospitalized at an Italian tertiary hospital from April 2020 to March 2021 were evaluated for enrollment in an observational, monocentric trial. The study population was composed of two groups of adult patients. In the first group (biopsy group, 30 patients), patients were eligible for inclusion if they had mild to moderate disease and if they agreed to have a rectal biopsy; in the second group (surgical specimen group, 6 patients), patients were eligible for inclusion if they underwent intestinal resection during index hospitalization. Fifty-nine intestinal mucosal samples were analyzed. RESULTS: Viral RNA was not detectable in any of the rectal biopsies performed (0/53). Histological examination showed no enterocyte damage, but slight edema of the lamina propria with mild inflammatory lymphoplasmacytic infiltration. There was no difference in inflammatory infiltrates in patients with and without GI symptoms. SARS-CoV-2 RNA was detected in fecal samples in 6 cases out of 14 cases examined (42.9%). In the surgical specimen group, all patients underwent emergency intestinal resection. Viral RNA was detected in 2 surgical specimens of the 6 examined, both of which were from patients with active neoplastic disease. Histological examination also pointed out abundant macrophages, granulocytes and plasma cells infiltrating the muscular layer and adipose tissue, and focal vasculitis. CONCLUSION: Mild-moderate COVID-19 may not be associated with rectal infection by the virus. More comprehensive autopsies or surgical specimens are needed to provide histological evidence of intestinal infection. Baishideng Publishing Group Inc 2022-11-28 2022-11-28 /pmc/articles/PMC9730443/ /pubmed/36504555 http://dx.doi.org/10.3748/wjg.v28.i44.6282 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Cuicchi, Dajana
Gabrielli, Liliana
Tardio, Maria Lucia
Rossini, Giada
D’Errico, Antonietta
Viale, Pierluigi
Lazzarotto, Tiziana
Poggioli, Gilberto
Virological and histological evaluation of intestinal samples in COVID-19 patients
title Virological and histological evaluation of intestinal samples in COVID-19 patients
title_full Virological and histological evaluation of intestinal samples in COVID-19 patients
title_fullStr Virological and histological evaluation of intestinal samples in COVID-19 patients
title_full_unstemmed Virological and histological evaluation of intestinal samples in COVID-19 patients
title_short Virological and histological evaluation of intestinal samples in COVID-19 patients
title_sort virological and histological evaluation of intestinal samples in covid-19 patients
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730443/
https://www.ncbi.nlm.nih.gov/pubmed/36504555
http://dx.doi.org/10.3748/wjg.v28.i44.6282
work_keys_str_mv AT cuicchidajana virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT gabriellililiana virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT tardiomarialucia virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT rossinigiada virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT derricoantonietta virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT vialepierluigi virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT lazzarottotiziana virologicalandhistologicalevaluationofintestinalsamplesincovid19patients
AT poggioligilberto virologicalandhistologicalevaluationofintestinalsamplesincovid19patients